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Abstract
We seek to understand which firms excel at innovation and commercialization. In doing so, we first ranked
companies that performed well on four measures: spending on R & D Spending (2006), Patenting (cumulative 2006 and 2007) and Commercialization of Innovations (cumulative for 2007 and 2008). We then compared our rankings with that of Business Week/Boston Consulting Group’s annual ranking of the most innovative companies, which primarily is based on reputation measured as perceptions among sitting CEO’s. Somewhat surprisingly, there is not complete overlap between our more quantitative ranking and the one done by
Business Week/BCG, and we highlight the reasons why. Second, we tested the relationship among R & D,
patents, and product releases and the role they play in driving revenue. We found that although innovation and
commercialization are different, they need to be considered together, that perceptions and reality in this realm
often do not match, and that joint innovation and commercialization activities can influence the bottom line.
Keywords: R & D, Patents, Technology, Investment, Product Releases, Commercialization of Innovation,
Revenues

1. Introduction
To survive firms must continue to innovate and successfully commercialize these innovations, whether by creating significant improvements to existing products in
order to maintain or grow market share, or by creating
entirely new products that potentially drive new markets
[1-4]. With increasing globalization, environmental complexity, economic uncertainty, intense competition and
pressure to perform that ensues, means that the need to
bring innovations to market successfully is greater than
ever. As a result, research on and rankings of the world’s
most innovative companies, and how they achieve this
status, is useful and timely in a variety of ways. Despite
the recognition of the importance of commercialization
of innovations within the general management literature,
[1-4], the research activities within the reputation literature have generally ignored innovation and commercialization.

Further, popular rankings of firms based on their innovative capabilities has been done primarily using
measures based on the perceptions of CEO’s rather than
using measures of definitive activities and hard outcomes
within firms. We feel there is need for a better understanding of the role that innovation and commercialization play in firm success.

2. Research on, and Rankings of, Firms That
Are Good at Innovation
A number of books in the popular business press have
been written in recent years with prescriptions for how
firms can be innovative. They tend to be based more on
the qualitative, anecdotal experiences that the authors
have had with relatively limited sets of companies.
Nonetheless, they are helpful insofar they offer useful
suggestions for what might work and what might not
work in specific types of companies. Beyond that, there
TI
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is a need for research that systematically looks across
many firms and helps us to understand with greater confidence exactly how the good firms innovate. Toward
this end, Business Week, together with the Boston Consulting Group, began publishing their annual ranking of
the top innovative firms. Their ranking looks across a
wide variety of firms and is based on a survey of sitting
executives and who they perceive to be the most innovative firms. Their ranking thus tells us who has the best
reputation for innovation among active CEOs.

3. What Does It Mean to Be an Innovative
Company?
We seek to build on existing research and understand
which firms are best at innovating, and why. More to the
point, we seek to understand why some firms are better
at commercializing innovations than are others, because
a firm can be innovative and not necessarily be successful. There exist a set of specific characteristics within
firms, together with a set of environmental factors that
serve to either enable or inhibit firms in their efforts to
commercialize innovation. Below we highlight a shortlist of those factors that we believe are the best indicators
of whether or not a firm is successfully commercializing
innovation; that is, what are they actually doing that
helps them continually to commercialize innovations.
Firms that are the best at commercializing innovation
over time are very good at maximizing their innovation
chain. We define the innovation chain as the sequence of
events in a firm that include spending on research and
development, protecting intellectual property (e.g., patent
protection), launching new products and/or services, and
consequently performing well financially.

3.1. The Innovation Chain (Figure 1)
Firms must continue to successfully innovate and com-
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Patent
Protection

Continuous Process Innovations

mercialize these innovations whether by creating new
products and services that drive new markets or by creating innovations that enable them to hold on to niches in
existing markets [1-4]. It is often a mistake to assume
that innovation is limited to product innovation driven by
R & D. Other means of innovation, for example, include
firms improving efficiency by continually looking for
ways to run themselves better, which has been defined
by others as continuous process innovation. Similarly,
firms can “acquire” innovation via mergers, acquisitions,
and joint ventures with other firms that possess innovative products, services, technologies, and other forms of
intellectual property. This can be particularly useful in a
situation where a firm needs to be in a specific market
quickly and does not have sufficient time to develop its
own capabilities and corresponding products for that new
market opportunity. All these are examples of ways that
a firm can be innovative, but they do not necessarily
represent the extent to which a firm is successful at continually commercializing innovations over time.
Similarly, the economic conditions within which a
firm operates can influence a firm’s ability to innovate
and commercialize. Poor economic conditions, for example, may make it difficult to acquire the capital necessary to develop new products, or may cause customers
to choose to hold back on their purchases and not buy the
innovative new products that companies are producing.
We believe that these macro-level economic factors are
important, but they do not tell us about a firm’s core innovation chain and related capabilities. We therefore
hold them constant.
3.1.1. Commercialization
The commercialization of innovations involves the act of
bringing innovations and to market [2,5-9]. Past research
has also posited that successful commercialization of
innovation is necessary in order for firms to be competitive [2,10], and is necessary to advance the economy at
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Figure 1. Innovation chain.
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large [1,3,4,11]. “New product introduction is an important measure of innovativeness, because it indicates the
potential commercial significance of a firm’s innovation
activities” [12,13].
Innovation cannot influence firm performance until
the ideas have been introduced to the market [12]. In
other words, an innovation “ideated” in a firm can only
become a successful innovation if it has a marketable use
[14]. Past research has shown that innovation ideation
does not always automatically lead to innovation commercialization [15,16]. Firms depend on products and
services developed three to five years ago for large portions of their current sales and as a result can find themselves aiming at an elusive target that is years in the future as they try to compete in a marketplace today [2,17].
Most single innovations can be duplicated and so just
being innovative does not guarantee a sustained competitive advantage. However, innovations are harder to imitate if they are successfully commercialized followed by
successive innovations in the area. While the literature
links firm innovations with firm performance, we propose
that innovation in its solitary state cannot achieve an advantage that is sustainable. Rather, it is commercialization followed by successive evolutionary innovation that
leads to sustained competitive advantage for a firm.
3.1.2. R & D Activities
The importance of R & D, for both internally developed
and capitalizing on externally acquired innovations, is
well established and well understood. Beyond that research on what R & D means to the firm is wide ranging.
For example, firms are continuously looking into ways to
reduce R & D costs, while not reducing the R & D activities [18], and relatedly, universities impact industrial
R & D through several channels [19]. A firm’s geographic location, alliances with other institutions and
organizations and R & D expenditures are representative
of knowledge flows, while products in the pipeline, firm
citations and patents are indicative of knowledge stocks
[20]. Dutta & Weiss (1997) linked technological innovativeness with partnership agreements. Their sample of
technologically innovative companies were proxied from
companies that invested heavily in R & D [21]. R & D
spillovers are, potentially, a major source of innovation
[22]. During times of austerity firms must tighten their
belts, subject nascent product-development programs to
rigorous screening, and train R & D staffers to think in
business terms so they will be better able to decide
whether an idea for a product or service is worth pursuing in the first place [23]. International diversification is
also positively related to R & D intensity [24]. Based on
a study of 137 Japanese firms, a positive link was found
between R & D and a firm’s inventive activities [25].

Firms often conduct international R & D to tap into
knowledge bases that reside in foreign countries [26].
Penner-Hahn and Shaver argued that in order to benefit
from international R & D investments, firms must already possess research capabilities in underlying or
complementary technologies. Also, R & D intensity is a
positive moderator between exploration and exploitation
and environmental conditions [27]. Finally, stage of the
R & D process moderates the relationship between the
wealth effects, technology, and market variables [5].
3.1.3. Patenting
Patents are physical, codifiable manifestations of innovative ideas that embody the knowledge of one or several
employees [20]. Patents often have been used as a proxy
for innovations. It has been measured as: patents as inventions [20,28,29], patents as a solution to a technical
problem [12], patents as firm knowledge [20,29], patents
as firm technological knowledge [14], patents as firm
technological innovation [21], and patents as innovative
output [26].
Patents are seen as a reliable indicator of a firm’s intermediate innovation-output [26]. Consequently, they
have been extensively used in several empirical studies
in strategy and economics as a means to capture a firm’s
intermediate innovative output and substantiate a firm’s
innovation ideation. Patents have been used as a proxy
for invention outcomes, which has been modeled to precede innovation commercialization [2,28]. Patents have
been used as an indicator to measure firm’s new knowledge creation efforts and its impact on future innovative
outcomes [14]. They have also been used to measure the
stock of innovative knowledge held by a firm [18,20]. In
addition, patents have been used to reflect production of
ideas at a country level [30,31].
Knowledge embodied in patents represents significant
and important innovations that can be commercialized
into new products or services with potential financial
returns. Patents allow us to better capture the outcome,
effort and activities of innovative knowledge creation,
and they increase the potential returns of commercialization. Thus, patents are widely accepted measures by policy makers and analysts [32] in terms of technology
strategy and competitive analysis.
3.1.4. Financial Performance
Briefly, financial performance has been measured as
accounting or market based measures. For example some
of the firm performance measures used for R & D, patents,
and product launches were, return on assets, return on
sales, stock return, sales growth or profit margin, revenue,
and market value [20,24,28,33]. Market measures also
have included, cumulative abnormal-return [34].
TI
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4. Methods
4.1. Data Collection
Guided by prior research, as embedded in our visualization of the innovation chain, we gathered data on: 1)
corporate spending on research and development, 2)
protection of intellectual property, 3) new product and/or
service launches, and 4) financial performance, and we
chose for this initial analysis simply to look at revenues
given that they are more an indicator of consumers’ demand and desire for a particular firm’s products, as opposed to a measure such as profits that would also indicate a firm’s capability to manage itself well. We were
interested in determining not only which firms are the
best within each category but, more importantly, which
of them are the best overall, which we take as a proxy for
successful commercialization of innovation. While we
believe that there are other factors that influence a firm’s
ability to commercialize innovation, such as continuous
process innovation, mergers, acquisitions, joint ventures,
and macro economic conditions, we focused our analysis
on the core processes that we believe comprise the innovation chain. We did not restrict ourselves to only the
Fortune 1000-firms, thus our list includes foreign firms
operating in US.
For R & D we collected data on overall spending of
firms on research and development in U.S. dollars for the
year 2007 from Fortune’s annual data on R & D spending. We collected data on revenues for American corporations from the Fortune 1000 lists for the period 2008.
For organizations outside the US we created a list of
those international firms that do well on our three prior
measures and then used other sources (such as their own
performance reports) to ascertain their annual sales
revenues.
For patents we collected data from the U.S. Patent Office Web site that shows all submissions for patents from
companies during the years 2006 and 2007. For product
launches (commercialization of innovations) we collected data on product launches directly from corporate
Web sites where we found formal announcements such
as dated press releases. We agreed on a protocol for capturing these announcements, and then one of our three
authors captured the announcements and a second author
checked them for accuracy and consistency. We tracked
formal press releases announcing the release of new
products and/or services (including significant product/
service enhancements) for the year 2007, and 2008. We
aggregated the number of new products and services
introduced to the market by a firm over two-periods from
2007 (considering a one-year lag to patent applications)
to measure commercialized innovation.

Appendix 1 shows the data we collected within each
of the four categories and the overlap with the Business
Week/BCG rankings.

4.2. Statistical Tests
For the purpose of this paper we needed to see the compactness among three of the three dimensions of innovativeness: R & D spending (2006), Patenting (cumulative
2006 and 2007) and Commercialization of Innovations
(Cumulative for 2007 and 2008). We also needed to see
the impact of those three variables on Revenues for year
2008, 2009 and 2010. We thus needed to estimate a system of equations. In such cases, two stage least squares
regression (2SLS) and Path Modeling (a variant of Structural Equation model) are both feasible approaches to
account for the potential for correlation in the errors
across estimated equations [35]. We used Structural Equation Modeling (SEM) with no latent variables to test our
research model. Compared to a 2SLS, path modeling provides a better approach to test our model by allowing us
to better assess the simultaneous effect of all the variables.

5. Findings
5.1. Statistical Tests
Figure 2 and Table 1 show the results of the statistical
analysis. R & D explains variance in number of patents
(R2 = 0.085; β = 0.292; p < 0.05) and commercialized
innovations (R2 = 0.025; β = 0.183; p < 0.05). Further, as
expected the number of patents also explains variance on
commercialized innovations (R2 = 0.025; β = 0.183; p <
0.05). Thus, also as expected the three of the four dimensions of innovations were linked.
The relation of these three variables (R & D, Patents,
and commercialized innovations (CI) with respect to
revenues is more complicated. The collective impact of
R & D, Patents, and CI on revenues for the years, 2008,
2009 and 2010 are R2 = 0.350 (p < 0.001), R2 = 0.248 (p
< 0.001), and R2 = 0.266 (p < 0.001), respectively. While
the three variables collectively explain variance in revenue, the paths from Patents and CI to revenue remained
non-significant. An interesting observation is that as we
moved revenues from 2008 through 2010, while the collective explanatory power decreased, the explanatory
power of CI and Patents on Revenues increased. For instance the path coefficients from patents to revenue,
despite remaining non-significant, increased from β =
0.019 in 2008 to β = 0.020 in 2009 to β = 0.132 in 2010.
Similarly, the path coefficients from CI to revenue increased from β = 0.075 in 2008 to β = 0.127 in 2009 to β
= 0.135 in 2010. An explanation for this is that R & D
TI
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Revenue at Year 1: R(Y)
R2= .350**
β=.616** (from R&D)
β=.019 Non‐Sig (From patents)
β=.075 Non‐Sig (from
Commercialized Innovations)

R&D Spending

β=.292*
Revenue at Year 2: R(Y+1)
R2=.248**
β=.501**
β=.020 Non‐Sig (From patents)
Β=.127 Non‐Sig (from
Commercialized Innovations)

No of patents
R2=.085*

β= .183*
β= .299*
Revenue at Year 3: R(Y+2)
R2=.266**
β=.484**
β=. 132 Non‐Sig (From patents)
β=. 135 Non‐Sig (from
Commercialized Innovations)

Commercialized
innovations
R2=.025* (from R&D)
R2= .089* (from patents)
*p<. 05; **p<.001

Figure 2. Variance model with statistical results.
Table 1. Results of the regressions.
Antecedents

Consequents

R2

Path

Beta

R&D

Patents (P)

0.085*

R&DP

0.292*

R&D

Commercialized innovations (CI)

0.025*

R & D  CI

0.183*

Patents (P)

Commercialized Innovations (CI)

0.089*

P  CI

0.299*

R & D  R(Y)

0.616**

P  R(Y)

0.019 (Non-Sig)

CI  R(Y)

0.075 (Non-Sig)

R & D  R(Y + 1)

0.510**

P  R(Y + 1)

0.020 (Non-Sig)

CI  R(Y + 1)

0.127 (Non-Sig)

R & D  R(Y + 1)

0.484**

P  R(Y + 1)

0.132 (Non-Sig)

CI  R(Y + 1)

0.135 (Non-Sig)

R & D, P, CI

R & D, P, CI

R & D, P, CI

Revenue Year (Y)

Revenue Year (Y + 1)

Revenue Year (Y + 2)

0.350**

0.248**

0.266**

*p < 0.05; **p < 0.001.

and revenues are highly correlated and there is a lag time
from R & D spending to patents and from patents to
commercialized products. Also, per extant research there
is a lag time between product release and diffusion of the
product into the market [36]. These lag times impact the
effect of patents and subsequently CI on revenues. Although insignificant early on, the impact of patents and
CI on revenues increases in subsequent years when
products diffuse in the market.

5.2. A Deeper Look at the Most Innovative
Firms
5.2.1. Who Are Spending the Most on R & D?
The top ten R & D spenders were, in order: Pfizer, Ford,
Johnson & Johnson, DaimlerChrysler, Toyota Motor,
GlaxoSmithKline, General Motors, Seimens, Microsoft,
and Samsung Electronics. These firms represent a variety
of industries, though one industry (automobile manufacTI
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turing) has four of the top ten spots. These ten firms also
spent in excess of $68 billion on research and development that year. Surprisingly, there is only a 44% overlap
between this list of top R & D spenders and the BusinessWeek/BCG list of top innovators. Some of the top R
& D spenders not ranked by BusinessWeek were, Ericsson (now Sony Ericsson), Matsushita Electric (now
Panasonic Corporation), Texas Instruments, Nissan, Hitachi, Renault, Sun Microsystems, and Toshiba. Apparently, heavy spending on R & D does not necessarily
translate perfectly into perceptions among sitting CEOs
that a company is a top innovator.
5.2.2. Who Had the Most Patent Submissions?
The top ten firms for patent submissions for that period
were IBM, Samsung Electronics, Canon, Matsushita
Electric (Panasonic Corporation), Intel, Microsoft, Toshiba, Micron Technology, Hewlett Packard, and Sony,
respectively. These top ten firms submitted applications
for over 19,000 patents during that time period. IBM
alone submitted over 3000 patents. This list clearly is
dominated by electronics manufacturers. As with R & D
spending, we found a 40% overlap with the Business
Week/BCG ranking on the dimension of patent protection. Some of the prominent organizations not present in
the ranking by BusinessWeek/BCG were Canon, Matsushita, Micron Technology, Hitachi, and Texas Instruments.
5.2.3. Who Had the Most Product Launches?
The top ten for firms releasing new products and/or services for that time period includes Microsoft, LG Electronics, Fujitso, Freescale Semiconductor, Toshiba, Hewlett Packard, Texas Instruments, Samsung Electronics,
STMicroelectronics, and Sharp Kabushiki Kaisha (Sharp
Corporation), respectively. These top ten firms formally
announced the release of over 1900 new products and/or
services during that time period- a high number considering that these came from only ten firms. As with patent
submissions this list is dominated by electronics manufacturers.
There is also only a 38% overlap between our list on
new product/service launches and that of BusinessWeek/
BCG. Among the more prominent firms on our list that
are not ranked by BusinessWeek/BCG are, Fujitso, Toshiba, Sharp, Oracle, Dow Chemical, Sun Microsystems,
Seiko Epson Corporation, Matsushita, and GlaxoSmithKline. Given that among the three measures we’ve discussed above this measure of new product/service
launches is perhaps the most visible and public of the
three, it is surprising that the degree of overlap between
this measure and the Business Week/BCG ranking is so
low in the absolute sense and has the lowest overlap of

our three measures thus far. The CEO’s surveyed by
Business Week/BCG as to their perceptions of the top
innovators is not influenced by public product and service launches as much as may be expected.
5.2.4. Who Are Generating the Most Revenue?
The top ten firms in revenue generation for this time period include BP, Wal-Mart, Exxon Mobile, General Motors, DaimlerChrysler, Toyota Motor, GE, Ford, Volkswagen, and Seimens. These top ten firms generated over
$2260 billion during time period for the study. Interestingly, this list is dominated by five automobile manufacturers. There is a 48% overlap with the BusinessWeek/
BCG ranking, suggesting that financial performance is
perhaps weighted higher than are other capabilities in the
minds of sitting CEOs as they rank the top innovators.
Some of the most prominent firms on our revenue list
that are not ranked by BusinessWeek/BCG were, Nissan
Motors, British Petroleum, Siemens, Nestle, Matsushita,
Toshiba, Unilever, Dow Chemical, and GlaxoSmithKline.
5.2.5. Which Firms Did Well on All Four Attributes?
Recall that our belief is that you must look at how well
firms are actually commercializing innovations. That
means you must look at the actual activities that a firm
engages in that enable commercialization, which we describe as the innovation chain and is comprised of R & D
spending, patent protection, new product/service launches,
and revenues. Appendix 2 shows the positioning of firms
on each of these four dimensions. Each of the columns
shows the ranking of the top 50 firms on that particular
dimension, and the grey-scale coding within that table
represents how many of the columns that firm appears.
Firms coded in dark grey appeared in the top 50 within
all four categories. Firms coded in one shade lighter grey
are in the top 50 within three categories. Firms in two
shades lighter grey appeared in two categories, and firms
in white appeared in one category. Appendix 3 shows
which firms appeared in all four categories, a total of 15
firms. It also shows which firms appeared in three of the
four categories, a total of 16 firms. The 15 firms that
performed well on all four aspects of the innovation
chain invested heavily in research and development,
worked hard to protect their intellectual property in the
form of patent submissions, launched a relatively high
number of new products and/or services, or at least released a relatively high number of significant upgrades
and enhancements to their offerings, and also generated a
large amount of revenues. We list these firms alphabetically and purposefully do not make any judgments about
the relative rankings within this list of 15. We believe
that all of these 15 can be thought of as great innovators
TI
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and commercializers of their innovations. Given that
they represent diverse industries, and thus have to contend with different economic and environmental factors,
it would be difficult to make meaningful comparisons. It
is worth noting, however, that these 15 firms are dominated by 10 electronics manufacturers of various types,
with an additional 3 automobile manufacturers, 1 aircraft
manufacturer, and 1 software firm. Of these 15 firms, 7
came from the USA (2 from Washington State, 2 from
Michigan, 1 from Illinois, 1 from New York and 1 from
California), 5 from Japan (4 from Tokyo, 1 from Osaka),
and 1 each from Finland, Germany and South Korea. The
16 firms that performed well on three dimensions shows
a similar trend in terms of industry representation, including 10 electronics firms, 3 automobile manufacturers,
2 consumer products companies, and 1 pharmaceutical
firm. Of these 16 firms, 8.5 came from USA, 3 from Japan, 1.5 from Germany, and 1 each from Korea, UK and
the Netherlands.

5.3. Comparisons with Business Week/BCG:
Perceptions and Reality
Surprisingly, among our top 15 firms that appeared in the
top 50 on all four of our innovation chain dimensions,
only 8 out of the 15 (53 percent) also appear in the Business Week/BCG rankings of the top innovators. The 16
firms that performed well on at least three of our four
dimensions fared slightly better on the Business Week/
BCG rankings (11 out of 16 firms, or 69 percent of them).
Among the most noteworthy firms that did well on our
quantitative measures but did not appear in Business
Week/BCG’s more qualitative ranking were Bosch, Hitachi, Nissan Motors, Sun Microsystems, and Toshiba
(see Appendix 4), all of which are foreign..
That anomaly aside, the perceptions of sitting CEO’s
as captured in the Business Week/BCG ranking do not
match reality as well as one would expect. Our prior
analysis of each of the four dimensions suggested that
the most overlap between our analysis and the Business
Week/BCG ranking occurred on the dimension of revenues. As already suggested, the perceptions of sitting
CEO’s as to who are the most innovative firms is perhaps influenced more by financial performance than innovation and commercialization. We find it interesting
that there are firms that perform well on each of the dimensions of the innovation chain and, yet, do not appear
in the Business Week ranking. One explanation is that
these firms are successfully commercializing innovations,
but their reputation for being a great innovator does not
match their actual success at doing this. Conversely,
there are firms that appear on the Business Week ranking

and do not appear on our lists. For example Ebay, Amazon.com, or Google, despite not performing well on
measures of the innovation chain were listed by CEOs as
being top innovators, perhaps because of the ubiquitous
presence of these firms or the innovative nature of their
business models.
We are not discounting organizations like Amazon’s
and Google’s innovative capacity; rather, we believe
they are not successful at commercializing innovations in
the classic sense as we measure it here. Amazon, Google,
and Apple are organizations that are well known among
CEOs and everyone else, while a company such as Fujitso has products that rest deep inside a computer and
are not as well known. Similarly, the Business Week/
BCG ranking lists Walmart, Costco, and McDonalds as
top innovative companies. While one can argue that
these firms might have innovative business models,
pricing strategies, or other tactics, the same cannot necessarily be said of their ability to take their own new
products to market. The point here is not that the Business Week/BCG ranking is flawed or not useful. We
believe that their ranking is well done and very useful.
On the one hand, while reputation is important, we believe that one should also consider hard measures of innovation and of commercialization. Equally, our more
quantitative measures do not tell the entire story. Ideally,
a firm would need to perform well on all four dimensions
of the innovation chain and have a great reputation for
innovation. To do well on all of our four dimensions and
the Business Week/BCG ranking, as 9 firms did, could
be considered the most comprehensive measure of success. These firms are commercializing innovations successfully and are well known for doing so.

5.4. Are We Missing Any Other Great
Innovators?
In our research we also uncovered a number of firms that
do not necessarily do well either in our analysis of the
innovation chain or on Business Week’s ranking of top
innovators, and yet these firms are clearly innovative and
creating value. These firms (Appendix 5) are not necessarily spending lots of money on R & D, they are not
filing for lots of patents, they are not necessarily launching many new offerings, they do not have the scale in
revenues that some of the firms did in our analysis above,
but they are clearly very innovative firms that are adding
lots of value for consumers and to the economy at large.
They likely did not show up in our analysis simply because these firms are not making their own products in
the classic sense. These firms deserve a form of “honorable mention” in any treatise on firms that are good at
commercializing innovation.
TI
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6. Discussions

We found that R & D, Patenting and Product and Service
releases (CI) are tightly linked. However, the role that
the three variables play with respect to Revenue was
slightly ambiguous. While the three variables collectively explain variance in revenue, the paths from Patents
and CI to revenue remained non significant. An interesting observation is that as we moved forward to look at
revenues in subsequent years, the explanatory power of
CI and Patents on Revenues increased. The explanation
for this is that there is a lag time from R & D spending to
patents and from patents to commercialized products.
Also there is a lag time between product release and diffusion of the product into the market [36]. These lag
times impact the effect of patents and, subsequently,
product releases on revenues. Although statistically not
significant early on, the impact of patenting and commercialization of innovations on revenues increases in
subsequent years. These investments appear to indeed
pay off over time.

their ranking of innovative firms. There was just over 60
percent overlap among top firms on our measures versus
those in the Business Week/BCG ranking. One puzzling
element to our data was that there was relatively little
overlap between our measure of product and service
launches and the Business Week measure of CEO perceptions of innovation. We would have expected more
overlap on those two measures given how “public” product launches can be. Perhaps not surprising, there was
greater overlap between our measure of revenues and the
Business Week measure of CEO perceptions of innovation. That tells us that the perceptions of sitting CEOs as
to who are the great innovators are driven by size and
financial success. In any event, we believe that both our
approach and the Business Week/BCG approach taken
together provide a useful look into how to be successful
at innovating and to be well known for it. In addition, we
provided some empirical evidence that activities toward
commercialization of innovation can impact revenues
downstream. We believe that collectively this work is not
only useful for those studying organizations, but for
those working in, managing, directing, and investing in
them as well.

6.2. Conclusions

6.3. Future Opportunities

Being innovative is one of the key attributes to a firm’s
success. Business Week together with the Boston Consulting Group identifies and ranks the top innovative
firms, which provides a useful accounting each year of
the best of the best. This annual list highlights in particular those top firms that have an excellent reputation
for innovation. Through our research we aimed to supplement the Business Week/BCG approach, and so we
looked specifically at the commercialization of innovation. We focused on the innovation chain within companies and collected data on spending in R & D, patent
submissions, product/service releases, and revenues, and
then showed who was the best at each of these criteria,
and then across all of the criteria.
Our approach shows that there are 15 firms that excel
at all four aspects of the innovation chain as we measured them, and another 16 firms that excel at three aspects. Perhaps not surprising, these top firms were
dominated by electronics manufacturers, although among
the top firms were an airplane manufacturer, a software
firm, some consumer products firms, and a pharmaceutical giant. In any event, each of these firms is doing what
it takes to successfully commercialize innovation. Our
approach was more quantitative in nature and measured
data on several key activities within the firm, and as a
result our results differed from those from the more
qualitative approach taken by Business Week/BCG in

Like any other approach to research ours is not without
its own limits and weaknesses. Our approach does not,
for example, differentiate between product launches and
significant product enhancements. It would be useful in
future to be able to distinguish between a new product
release like Windows Vista as opposed to enhancements
like new service packs (i.e., incremental upgrades to the
Vista operating system). We could also in future distinguish better between types of products. For instance, a
release of a new mouse by Microsoft is not necessarily
the same as the release of a new model of airplane by
Boeing.
Another future path for this research would be to perform a causal, time-series analysis where one would look
at R & D spending, patent protection, and new product/
service launches in one year and see how these variables
influence revenues in subsequent years. Further, we
could control for macro-economic conditions, process
innovations, and a firm’s merger and acquisition activity
to see what effect these have on commercialization of
innovation versus the effect of our innovation chain
variables. One other fruitful line of research may be to
determine what effect these real and perceived measures
of innovation and commercialization have on stock price,
which can be thought of as the market’s collective perception of the value of a firm. We acknowledge that our
research approach may be biased more toward firms that

6.1. Summary
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design, develop, and produce their own products, try to
protect them legally, and take them to market (i.e., classic manufacturing organizations). It is clear that a lot
remains to be done in helping us to better understand
commercialization of innovations, not only in terms of
better understanding the construct, but also in merging
the gap between related perceptions and realities. This,
we believe, would also lead to a better understanding of
corporate reputation and help to understand why it is that
we believe some firms to be better than others at core
functions such as being innovative. We hope that our
work at least offers a good beginning and suggests some
fruitful avenues for future research.
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Appendix 1
Top 50 organizations in the innovation chain.
R & D Ranking
Patents
(Business week Overlap = 44%) (Business week Overlap = 40%)

Commercialization of
Innovations (Business week
Overlap = 38%)

Revenue
(Business week Overlap = 48%)

Rank
Organization

R & D in
USD millions

Organization

Patents
Submitted in
2007

Organization

Product
Launches

Organization

Revenue in
USD millions

1

Pfizer

7600.18

IBM

3125

Microsoft

264

BP *

395062.85

2

Ford*

7205.67

Samsung
Electronics

2723

LG Electronics

246

Wal-Mart

351139.00

3

Johnson & Johnson

7145.42

CANON*

1983

Fujitso*

240

Exxon Mobil*

347254.00

4

DaimlerChrysler

6903.09

Matsushita Electric
(Changed name to
Panasonic
Corporation)*

1910

Freescale
Semiconductor*

228

General Motors*

207349.00

5

Toyota Motor

6821.32

Intel

1864

Toshiba*

226

DaimlerChrysler

203032.00

6

GlaxoSmithKline*

6767.08

Microsoft

1637

Hewlett Packard

166

Toyota Motor

174905.73

7

General Motors*

6635.17

Toshiba*

1519

Texas Instruments

156

GE

168307.00

8

Seimens*

6626.12

MICRON
TECHNOLOGY,
INC.*

1476

Samsung Electronics

150

Ford*

160126.00

9

Microsoft

6155.20

Hewlett Packard

1466

STMicroelectronics*

144

VOLKSWAGEN

139802.76

10

Samsung
Electronics

6146.01

Sony

1454

SHARP KABUSHIKI
KAISHA (SHARP
CORPORATION)*

126

Seimens*

114243.47

11

Intel

5873.41

Hitachi*

1381

Sony

116

VERIZON

93221.00

12

Sanofi-Aventis*

5808.41

Fujitso *

1293

Advanced Micro
Devices*

107

Samsung
Electronics

91731.42

13

IBM

5668.29

SEIKO EPSON
CORPORATION*

1205

General Motors*

105

Hewlett Packard

91658.00

14

VOLKSWAGEN

5592.11

GE

911

Dell

98

IBM

91424.00

15

Roche*

5398.67

Infineon
Technologies*

847

United Technologies*

94

NTT com*

89278.92

16

Novartis*

5364.83

Denso
Corporation*

753

Oracle*

93

Nestle*

83573.78

17

Nokia

4895.73

Texas
Instruments*

749

Nokia

88

Honda Motor

82387.45

18

merck

4776.20

RICOH
COMPANY, LTD.*

727

Dow Chemical*

88

Nissan Motors*

79935.59

19

Matsushita Electric
(Changed name to
Panasonic
Corporation) *

4740.73

Seimens

727

Hitachi*

87

Hitachi*

79074.85

20

Robert Bosch*

4481.60

LG Electronics

682

Broadcom*

82

Peugot*

75489.48

21

Sony

4463.87

Nokia

679

Cisco Systems

81

Matsushita Electric
(Changed name to
Panasonic
Corporation)*

74073.98

TI

267
22

Honda Motor

4284.15

Honda Motor

677

Nortel Networks*

81

France Telecom*

70560.57

23

BMW

4231.00

Fujifilm
Corporation

660

EMC*

75

Altria*

70324.00

24

Cisco Systems

3987.76

SHARP
KABUSHIKI
KAISHA (SHARP
CORPORATION)*

646

SUN
MICROSYSTEMS,
INC.*

72

BASF*

68651.13

25

Ericsson (aka:
SONY ERICSSON
MOBILE
CORPORATION)*

3925.14

SUN
MICROSYSTEMS,
INC.*

610

Ericsson (aka: SONY
ERICSSON MOBILE
CORPORATION) *

71

Proctor and Gamble

68222.00

26

AstraZeneca*

3902.59

Cisco Systems

580

SEIKO EPSON
CORPORATION*

66

FIAT*

67894.65

27

3M

3896.91

Robert Bosch*

568

Infineon Technologies*

66

Hundai*

67778.05

28

EADS*

3783.91

ROYAL PHILIPS
ELECTRONICS

547

Ford*

59

BMW (AKA:
BAYERISCHE
MOTOREN
WERKE AG)

65092.33

29

Nissan Motors *

3756.97

Honeywell*

538

Caterpillar*

59

AT&T

63055.00

30

Hewlett Packard

3574.66

Broadcom*

533

Electronic Arts*

59

Boeing

61530.00

31

Hitachi*

3400.22

3M

459

Motorola

55

Target

59490.00

32

AMGEN*

3367.25

Mitsubishi Electric*

459

RICOH COMPANY,
LTD.*

55

Sony

57972.28

33

Boeing

3261.09

Sanyo Electric*

454

Alcatel-Lucent**

53

Robert Bosch*

57456.42

34

Bayer*

3240.53

Boeing

428

IBM

52

Dell

57095.00

35

Renault*

3165.34

Motorola

411

EI du Pont de Nemours

52

Nokia

54397.00

36

Eli Lilly*

3138.20

EI du Pont de
Nemours*

369

Boeing

51

Unilever*

54314.42

37

Toshiba*

3126.31

Toyota Motor

351

BT

50

Renault*

53649.79

38

Wyeth*

3113.66

General Motors*

343

Johnson & Johnson

47

Johnson & Johnson

53324.00

39

Bristol
Meyers-Squibb*

3067.48

Freescale
Semiconductor*

322

Robert Bosch

46

Toshiba*

52988.22

45

Pfizer

52415.00

40

GE*

3029.53

Ford*

315

Matsushita Electric
(Changed name to
Panasonic
Corporation)*

41

Peugot*

2868.60

Advanced Micro
Devices*

304

GlaxoSmithKline*

44

EADS*

51834.36

42

Alcatel-Lucent*

2621.96

Applied Materials*

285

3M

42

LG Elecronics

49876.58

43

SUN
MICROSYSTEMS,
INC.*

2600.53

Genentech*

281

SAP*

42

Dow Chemical

49124.00

44

NTT com*

2589.09

Qualcomm*

278

Intel

38

United
Technologies*

47829.00

45

CANON *

2587.91

AT&T

273

Novartis*

36

GlaxoSmithKline*

45416.65

46

ROYAL PHILIPS
ELECTRONICS

2569.20

Nortel Networks*

272

Toyota Motor

35

Microsoft

44282.00

47

Finmeccanica*

2465.00

Nissan Motors *

268

DaimlerChrysler

34

Motorola

43739.00

TI

268
48

BAE Systems*

2442.96

Medtronic*

250

AT&T

34

Bayer*

42084.75

49

Abbott
Laboratories*

2247.63

Lockheed Martin*

240

GE

33

Caterpillar*

41517.00

50

Texas Instruments*

2194.50

BASF*

224

Proctor and Gamble

32

ROYAL PHILIPS
ELECTRONICS

40780.96

51

Schering-Plough*

7600.18

Proctor and Gamble

215

Sanofi-Aventis*

32

Fujitso*

40553.94

Appendix 2
Positioning of organizations in the innovative chain.
LEGEND
Appeared in 4 lists
Appeared in 3 lists
Appeared in 2 lists
Appeared Just once

By R & D Spending

By Patents

By commercialization of Innovations

Revenue

3M

3M

3M

BP

Abbott Laboratories

Advanced Micro Devices

Advanced Micro Devices

Altria

Alcatel-Lucent

Applied Materials

Alcatel-Lucent**

AT&T

AMGEN

AT&T

AT&T

BASF

AstraZeneca

BASF

Boeing

Bayer

BAE Systems

Boeing

Broadcom

BMW (AKA: BAYERISCHE
MOTOREN WERKE AG)

Bayer

Broadcom

BT

Boeing

BMW (AKA: BAYERISCHE
MOTOREN WERKE AG)

CANON

Caterpillar

Caterpillar

Boeing

Cisco Systems

Cisco Systems

DaimlerChrysler

Bristol Meyers-Squibb

Denso Corporation

DaimlerChrysler

Dell

CANON

EI du Pont de Nemours

Dell

Dow Chemical

Cisco Systems

Ford

Dow Chemical

EADS

DaimlerChrysler

Freescale Semiconductor

EI du Pont de Nemours

Exxon Mobil

EADS

Fujifilm Corporation

Electronic Arts

FIAT

Eli Lilly

Fujitso

EMC

Ford

Ericsson (aka: SONY ERICSSON
MOBILE CORPORATION)

GE

Ericsson (aka: SONY ERICSSON
MOBILE CORPORATION)

France Telecom

Finmeccanica

Genentech

Ford

Fujitso

Ford

General Motors

Freescale Semiconductor

GE

GE

Hewlett Packard

Fujitso

General Motors
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General Motors

Hitachi

GE

GlaxoSmithKline

GlaxoSmithKline

Honda Motor

General Motors

Hewlett Packard

Hewlett Packard

Honeywell

GlaxoSmithKline

Hitachi

Hitachi

IBM

Hewlett Packard

Honda Motor

Honda Motor

Infineon Technologies

Hitachi

Hundai

IBM

Intel

IBM

IBM

Intel

LG Elecronics

Infineon Technologies

Johnson & Johnson

Johnson & Johnson

Lockheed Martin

Intel

LG Electronics

Johnson & Johnson

Matsushita Electric (Changed name
to Panasonic Corporation)

Matsushita Electric (Changed name Matsushita Electric (Changed name
to Panasonic Corporation)
to Panasonic Corporation)
merck

Medtronic

LG Electronics

Microsoft

Microsoft

MICRON TECHNOLOGY, INC.

Matsushita Electric (Changed name
to Panasonic Corporation)

Motorola

Nissan Motors

Microsoft

Microsoft

Nestle

Nokia

Mitsubishi Electric

Motorola

Nissan Motors

Novartis

Motorola

Nokia

Nokia

NTT com

Nissan Motors

Nortel Networks

NTT com

Peugot

Nokia

Novartis

Peugot

Pfizer

Nortel Networks

Oracle

Pfizer

Renault

Proctor and Gamble

Proctor and Gamble

Proctor and Gamble

Robert Bosch

Qualcomm

RICOH COMPANY, LTD.

Renault

Roche

RICOH COMPANY, LTD.

Robert Bosch

Robert Bosch

ROYAL PHILIPS ELECTRONICS

Robert Bosch

Samsung Electronics

ROYAL PHILIPS ELECTRONICS

Samsung Electronics

ROYAL PHILIPS ELECTRONICS

Sanofi-Aventis

Samsung Electronics

Sanofi-Aventis

Samsung Electronics

SAP

Seimens

Schering-Plough

Sanyo Electric

SEIKO EPSON CORPORATION

Sony

Seimens

SEIKO EPSON CORPORATION

SHARP KABUSHIKI KAISHA
(SHARP CORPORATION)

Target

Sony

Seimens

Sony

Toshiba

SUN MICROSYSTEMS, INC.

SHARP KABUSHIKI KAISHA
(SHARP CORPORATION)

STMicroelectronics

Toyota Motor

Texas Instruments

Sony

SUN MICROSYSTEMS, INC.

Unilever

Toshiba

SUN MICROSYSTEMS, INC.

Texas Instruments

United Technologies

Toyota Motor

Texas Instruments

Toshiba

VERIZON

VOLKSWAGEN

Toshiba

Toyota Motor

VOLKSWAGEN

Wyeth

Toyota Motor

United Technologies

Wal-Mart
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Appendix 3
Organizations consistent with all (or most aspects of) the innovation chain.
Organizations appeared in all aspects of innovation value chain
Name

Commercialization
of Innovations

Patents

R & D Spending

Revenue

Considered By
Business Week

Boeing

Yes

Yes

Yes

Yes

Yes

Seattle, WA, USA

Ford

Yes

Yes

Yes

Yes

NO

Dearborn, MI, USA

General Motors

Yes

Yes

Yes

Yes

NO

Detroit, MI, USA

Hewlett Packard

Yes

Yes

Yes

Yes

Yes

Palo Alto, CA, USA

Hitachi

Yes

Yes

Yes

Yes

0

Tokyo, Japan

IBM

Yes

Yes

Yes

Yes

Yes

Armonk, NY, USA

Matsushita Electric (Changed name to
Panasonic Corporation)

Yes

Yes

Yes

Yes

NO

Osaka, Japan

Microsoft

Yes

Yes

Yes

Yes

Yes

Redmond, WA, USA

Motorola

Yes

Yes

Yes

Yes

Yes

Schaumburg, Il, USA

Nokia

Yes

Yes

Yes

Yes

Yes

Espoo, Finland

Robert Bosch

Yes

Yes

Yes

Yes

NO

Gerlingen, Germany

Samsung Electronics

Yes

Yes

Yes

Yes

Yes

Seoul, South Korea

Sony

Yes

Yes

Yes

Yes

Yes

Tokyo, Japan

Toshiba

Yes

Yes

Yes

Yes

NO

Tokyo, Japan

Toyota Motor

Yes

Yes

Yes

Yes

Yes

Tokyo, Japan

Geographic Locations

Organizations appeared in three out of four aspects of innovation value chain
Name

Commercialization
of Innovations

Patents

R & D Spending

Revenue

Considered By
Business Week

Geographic Locations

3M

Yes

Yes

Yes

No

Yes

Maplewood, MN, USA

AT&T

Yes

Yes

No

Yes

Yes

Dallas, TX, USA

Cisco Systems

Yes

Yes

Yes

No

Yes

San Jos, CA, USA

DaimlerChrysler

Yes

No

Yes

Yes

Yes

Chrysler  Auburn Hills,
MI, USA Daimler 
Stuttgart Germany

Fujitso

Yes

Yes

No

Yes

No

Tokyo, Japan

GlaxoSmithKline

Yes

No

Yes

Yes

Yes

London, UK

Honda Motor

Yes

Yes

Yes

Yes

Yes

Tokyo, Japan

Intel

Yes

Yes

Yes

No

Yes

Santa Clara, CA, USA

Johnson & Johnson

Yes

No

Yes

Yes

Yes

New Brunswick, NJ, USA

LG Elecronics

Yes

Yes

Yes

Yes

Yes

Seoul, South Korea

Nissan Motors

Yes

Yes

No

Yes

No

Tokyo, Japan

Procter and Gamble

Yes

Yes

No

Yes

Yes

Cincinnati, OH, USA

ROYAL PHILIPS ELECTRONICS

No

Yes

Yes

Yes

Yes

Amsterdam, Netherlands

Seimens

No

Yes

Yes

Yes

No

Berlin and Munich, Germany

SUN MICROSYSTEMS, INC.

Yes

Yes

Yes

Yes

No

Santa Clara, CA, USA

Texas Instruments

Yes

Yes

Yes

No

No

Dallas, TX, USA
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Appendix 4
Innovative firms that are not ranked by Business Week.
Some top innovative firms that are not ranked by Business Week
Hitachi
With an approximate R & D investment of $3.4 billion, Hitachi is ranked at 31 in terms of R & D Spending. With 1381 patent submissions, it is
ranked 11th in terms of patent protection. From January 2007 through June 2008 it has released about 90 products (enhancements and new releases), positioned at 18th in terms of product launches. With revenue around $80 billion, it is ranked at 19th.
Nissan Motors:
With an approximate R & D investment of $3.7billion, Nissan is ranked at 29in terms of R & D Spending. With 268 patent submissions, Nissan is
ranked at 47 in terms of patents. With only 30 product releases Nissan did not reach our top 50 in terms of product launches. With revenue around
$80 billion, it is ranked at 18th.
Robert Bosch
With an approximate R & D investment of $4.4 billion, Robert Bosch is ranked at 20 in terms of R & D Spending. With 568 patent submissions,
it is ranked 27th in terms of patent protection. From January 2007 through June 2008 it has released about 46 products (enhancements and new
releases), positioned at 39th in terms product launches. With revenue exceeding $57 billion, it is ranked at 33rd.
Sun Microsystems
With an approximate R & D investment of $2.6 billion, Sun Microsystems is ranked at 43 in terms of R & D Spending. With 610 patent submission, it is ranked 25th in terms of patent protection. From January 2007 through June 2008 it has released about 46 products (enhancements and
new releases), positioned at 39thh in terms of product launches. Sun Microsystems did not feature in our top 50 revenue generating organizations,
with revenue of $13 billion.
Toshiba
With an approximate R & D investment of $3.1 billion, Toshiba at 37 in terms of R & D Spending. With 1519 patent submission, it is ranked 7th
in terms of patent protection. From January 2007 through June 2008 it has released about 225 products (enhancements and new releases), positioned at 5th in terms of product launches. With revenue around 53 billion, it is ranked at 39th.
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Appendix 5
Innovative firms not captured by our rankings.
Some innovative companies not listed in our rankings
Google
Headquartered in Menlo Park, CA, and with annual revenues now approximately $22 billion, Google revolutionized web search. Not only has it
made search ubiquitous but it has also transformed the revenue models surrounding search engines. In addition to its own research and development,
Google also acquired the companies below in order to bring search engines, weather information, news, and social networking all under the same
umbrella. With these acquisitions Google is increasing the depth and breadth of search engines to include news, video, people, products, Web 2.0
and much more. All has helped the word “Google” to become synonymous with search.
1) Keyhole, Inc., led to the development of Google Earth
2) YouTube., Online Video posting and viewing site
3) JotSpot., a developer of wiki technology for collaborative Web sites
4) GrandCentral. Internet service that uses voice over internet protocol (VoIP) to link customers’ phone numbers together.
5) Orkut, Google+. Social Networking site.
6) Andriod: Mobile Operating System
IDEO
IDEO may physically produce and launch its own physical “products,” but they certainly help others to innovate. Based out of Palo Alto, CA,
IDEO has worked on thousands of projects for a large number of clients in the consumer, computer, medical, furniture, toy, office and automotive
industries. Notable examples are Apple’s first mouse, Microsoft’s second mouse, the Palm V PDA, and Steelcase’s Leap Chair. Major clients (as
of 2004) included Procter & Gamble, PepsiCo, Microsoft, Eli Lilly, and Steelcase.
Amazon.com
Based in Seattle, WA, and with annual revenue crossing the $19 billion mark in 2008, Amazon.com is the largest online retailer in the world.
Credit goes toAmazon.com in popularizing online shopping, to the extent that it the most used platform for product purchase and feature lookups. On
November 19, 2007, Amazon released its first product, the Amazon Kindle. The device used E Ink brand electronic paper displays and enables
users to download content over Amazon Whispernet using the Sprint EVDO Network. On March 3, 2009, Amazon. com launched Kindle for
iPhone in the App Store for iPhone and iPod Touch owners to read Kindle content. Through a technology termed “Whispersync,” customers can
keep their place across Kindle hardware devices and other mobile devices. Amazon announced the Kindle DX on May 6, 2009. This device has a
larger screen than its predecessors and supports PDF files natively. It is marketed as more suitable for displaying newspaper and textbook content.
There are many other innovative services (not products) offered by Amazon.com, such as A9.com, Alexa Internet, IMDb, and Amazon Web
Services.
Ebay
Based out of San Jose, CA, and with revenues over $8 billion annually, EBay is certainly responsible for the adoption and diffusion of online
auctioning. They also combined online auctioning with new services such as “buy it now”. EBay has also established localized websites in thirty
countries other than the United States. Ebay also owns Paypal, a trusted name in facilitating online payments. Other acquisitions of EBay include:
Skype, StubHub (an online marketplace for buyers and sellers of tickets for sports, concerts, theater and other live entertainment events at fair
market value, even for events that happen to be sold out), and Kijiji (a centralized network of online urban communities for posting local online
classified advertisements).
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